Selected Financial Data
since 2005
Income Statement
Abbott Laboratories, selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Net sales | Operating earnings | Net earnings |
|---|---|---|---|
| Dec 31, 2023 | 40,109) | 6,478) | 5,723) |
| Dec 31, 2022 | 43,653) | 8,362) | 6,933) |
| Dec 31, 2021 | 43,075) | 8,425) | 7,071) |
| Dec 31, 2020 | 34,608) | 5,357) | 4,495) |
| Dec 31, 2019 | 31,904) | 4,532) | 3,687) |
| Dec 31, 2018 | 30,578) | 3,650) | 2,368) |
| Dec 31, 2017 | 27,390) | 1,726) | 477) |
| Dec 31, 2016 | 20,853) | 3,185) | 1,400) |
| Dec 31, 2015 | 20,405) | 2,867) | 4,423) |
| Dec 31, 2014 | 20,247) | 2,599) | 2,284) |
| Dec 31, 2013 | 21,848) | 2,629) | 2,576) |
| Dec 31, 2012 | 39,874) | 8,085) | 5,963) |
| Dec 31, 2011 | 38,851) | 5,752) | 4,728) |
| Dec 31, 2010 | 35,167) | 6,088) | 4,626) |
| Dec 31, 2009 | 30,765) | 6,236) | 5,746) |
| Dec 31, 2008 | 29,528) | 5,694) | 4,881) |
| Dec 31, 2007 | 25,914) | 4,579) | 3,606) |
| Dec 31, 2006 | 22,476) | 2,042) | 1,717) |
| Dec 31, 2005 | 22,338) | 4,362) | 3,372) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Abbott Laboratories, selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 22,670) | 73,214) |
| Dec 31, 2022 | 25,224) | 74,438) |
| Dec 31, 2021 | 24,239) | 75,196) |
| Dec 31, 2020 | 20,441) | 72,548) |
| Dec 31, 2019 | 15,667) | 67,887) |
| Dec 31, 2018 | 14,632) | 67,173) |
| Dec 31, 2017 | 20,147) | 76,250) |
| Dec 31, 2016 | 26,776) | 52,666) |
| Dec 31, 2015 | 14,155) | 41,247) |
| Dec 31, 2014 | 15,261) | 41,275) |
| Dec 31, 2013 | 19,247) | 42,953) |
| Dec 31, 2012 | 31,323) | 67,235) |
| Dec 31, 2011 | 23,769) | 60,277) |
| Dec 31, 2010 | 22,318) | 59,462) |
| Dec 31, 2009 | 23,314) | 52,417) |
| Dec 31, 2008 | 17,043) | 42,419) |
| Dec 31, 2007 | 14,043) | 39,714) |
| Dec 31, 2006 | 11,282) | 36,178) |
| Dec 31, 2005 | 11,386) | 29,141) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Abbott Laboratories, selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total debt | Total Abbott shareholders’ investment | |
|---|---|---|---|
| Dec 31, 2023 | 13,841) | 14,679) | 38,603) |
| Dec 31, 2022 | 15,489) | 16,773) | 36,686) |
| Dec 31, 2021 | 13,105) | 18,050) | 35,802) |
| Dec 31, 2020 | 11,907) | 18,747) | 32,784) |
| Dec 31, 2019 | 10,863) | 18,139) | 31,088) |
| Dec 31, 2018 | 9,012) | 19,566) | 30,524) |
| Dec 31, 2017 | 8,912) | 27,924) | 30,897) |
| Dec 31, 2016 | 6,660) | 22,006) | 20,538) |
| Dec 31, 2015 | 9,186) | 9,001) | 21,211) |
| Dec 31, 2014 | 10,532) | 7,845) | 21,526) |
| Dec 31, 2013 | 9,507) | 6,561) | 25,171) |
| Dec 31, 2012 | 13,280) | 20,476) | 26,721) |
| Dec 31, 2011 | 15,480) | 15,415) | 24,440) |
| Dec 31, 2010 | 17,262) | 18,918) | 22,388) |
| Dec 31, 2009 | 13,049) | 16,456) | 22,856) |
| Dec 31, 2008 | 11,592) | 11,445) | 17,480) |
| Dec 31, 2007 | 9,103) | 12,214) | 17,779) |
| Dec 31, 2006 | 11,951) | 12,411) | 14,054) |
| Dec 31, 2005 | 7,416) | 6,634) | 14,415) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Abbott Laboratories, selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Net cash from operating activities | Net cash (used in) from investing activities | Net cash from (used in) financing activities |
|---|---|---|---|
| Dec 31, 2023 | 7,261) | (3,133) | (7,091) |
| Dec 31, 2022 | 9,581) | (1,740) | (7,636) |
| Dec 31, 2021 | 10,533) | (2,008) | (5,494) |
| Dec 31, 2020 | 7,901) | (2,215) | (2,779) |
| Dec 31, 2019 | 6,136) | (1,815) | (4,289) |
| Dec 31, 2018 | 6,300) | (1,356) | (10,391) |
| Dec 31, 2017 | 5,570) | (9,618) | (5,281) |
| Dec 31, 2016 | 3,203) | (248) | 11,147) |
| Dec 31, 2015 | 2,966) | 406) | (2,236) |
| Dec 31, 2014 | 3,675) | (202) | (2,742) |
| Dec 31, 2013 | 3,324) | (3,929) | (6,696) |
| Dec 31, 2012 | 9,314) | (6,081) | 716) |
| Dec 31, 2011 | 8,970) | 261) | (6,023) |
| Dec 31, 2010 | 8,736) | (12,188) | (1,088) |
| Dec 31, 2009 | 7,275) | (3,699) | 1,002) |
| Dec 31, 2008 | 6,995) | (2,087) | (3,486) |
| Dec 31, 2007 | 5,184) | (1,136) | (2,313) |
| Dec 31, 2006 | 5,262) | (11,398) | 3,622) |
| Dec 31, 2005 | 5,047) | (720) | (2,592) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Abbott Laboratories, selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 3.28 | 3.26 | 2.08 |
| Dec 31, 2022 | 3.94 | 3.91 | 1.92 |
| Dec 31, 2021 | 3.97 | 3.94 | 1.82 |
| Dec 31, 2020 | 2.52 | 2.50 | 1.53 |
| Dec 31, 2019 | 2.07 | 2.06 | 1.32 |
| Dec 31, 2018 | 1.34 | 1.33 | 1.16 |
| Dec 31, 2017 | 0.27 | 0.27 | 1.08 |
| Dec 31, 2016 | 0.94 | 0.94 | 1.05 |
| Dec 31, 2015 | 2.94 | 2.92 | 0.98 |
| Dec 31, 2014 | 1.50 | 1.49 | 0.90 |
| Dec 31, 2013 | 1.64 | 1.62 | 0.64 |
| Dec 31, 2012 | 3.76 | 3.72 | 1.67 |
| Dec 31, 2011 | 3.03 | 3.01 | 1.92 |
| Dec 31, 2010 | 2.98 | 2.96 | 1.76 |
| Dec 31, 2009 | 3.71 | 3.69 | 1.60 |
| Dec 31, 2008 | 3.16 | 3.12 | 1.44 |
| Dec 31, 2007 | 2.34 | 2.31 | 1.30 |
| Dec 31, 2006 | 1.12 | 1.12 | 1.18 |
| Dec 31, 2005 | 2.17 | 2.16 | 1.10 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.